[Evidence summary:] What is the current best evidence for virtual pulmonary rehabilitation for chronic obstructive pulmonary disease (COPD)in the context of the COVID-19 pandemic? [v2.0]
dc.contributor.author | National Health Library & Knowledge Service (NHLKS) | |
dc.contributor.author | Flynn, Maura | |
dc.contributor.author | O'Neill, Sinéad | |
dc.date.accessioned | 2021-03-23T10:46:46Z | |
dc.date.available | 2021-02-09T14:35:30Z | |
dc.date.available | 2021-03-23T10:46:46Z | |
dc.date.issued | 2021-03-22 | |
dc.identifier.uri | http://hdl.handle.net/10147/628951 | |
dc.description | Main Points Guidance is available from thoracic organisations internationally on pulmonary rehabilitation (PR) for COVID patients. A number of small studies and commentaries endorse the remote provision of PR as feasible and safe when provided by experienced PR clinicians. However, the need for high quality clinical research to strengthen the evidence base is acknowledged. A multidisciplinary approach to rehabilitation, inclusive of PR, is suggested by a number of commentators. It is recommended that patients’ individual needs and preferences are taken into consideration when creating a PR programme. Discussion in the literature regarding the tests and tools which can be used for remote PR is included in this summary. The importance of investment in digital connectivity and supports for telerehabilitation is emphasised in the literature. A number of on-going trials and reviews are being conducted on this topic, a selection of which are referenced herein. | en_US |
dc.language.iso | en | en_US |
dc.publisher | Health Service Executive | en_US |
dc.relation.ispartofseries | Question 178 | en_US |
dc.relation.ispartofseries | Question 176 [v2.0] | en_US |
dc.subject | CORONAVIRUS | en_US |
dc.subject | COVID-19 | en_US |
dc.subject | CHRONIC OBSTRUCTIVE PULMONARY DISEASE | en_US |
dc.subject | REHABILITATION | en_US |
dc.title | [Evidence summary:] What is the current best evidence for virtual pulmonary rehabilitation for chronic obstructive pulmonary disease (COPD)in the context of the COVID-19 pandemic? [v2.0] | en_US |
dc.type | Other | en_US |
refterms.dateFOA | 2021-02-09T14:35:31Z |
Files in this item
This item appears in the following Collection(s)
-
HSE Library Summaries of Evidence
Evidence summaries and reviews on the management and treatment of Novel Coronavirus Covid-19 and other clinical topics